Content
08/02/2024 Novato, CA USA
Ultragenyx completed $14 million Seed Round funding. Investors include GordonMD Global Investments.
#Biotech  #Life Science  
About
Amlogenyx research centers around an enzyme called protective protein/cathepsin A, or PPCA, which can break up a form of amyloid beta, the protein many consider responsible for Alzheimer's debilitating effects.
Startup
Ultragenyx
https://www.ultragenyx.com Claim Profile
Location:
Novato, CA USA
Sector:
Biotech
Life Science
Download StockFan App Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.